Poliomyelitis Articles & Analysis
10 news found
It is well accepted that vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like bacteria or viruses, which then keeps humans safe from the diseases they cause. Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...
ByNuvonis
AJ Vaccines’ production site-facility in Copenhagen, Denmark has been approved by the Gulf Health Council (GHC) effective 9 November 2020. The approval indicates the vaccine production is at a high standard which will help to secure timely patient access to vaccines in the Gulf Cooperation Council (GCC) countries and wider Middle Eastern region. In recent years, the regulatory requirements ...
Wastewater-based epidemiology (WBE) is the monitoring and analysis of wastewater in sewer systems to glean epidemiological information. The practice has already proven itself useful over the years. For instance, it provided early detection of a 2013 polio outbreak in Israel, and it already is an accepted tool to monitor legal and illegal drug use in a population. The list of uses for WBE is ...
The new vaccine will play a key role in the Global Polio Eradication Initiative (GPEI) The new Inactivated Polio Vaccine, Picovax®, is indicated for active immunization against poliomyelitis by primary vaccination of infants from the age of six weeks, and for revaccination of infants, children and adolescents. ...
Picovax® provides active immunization against poliomyelitis by primary vaccination in infants from the age of 6 weeks and for revaccination of infants, children, adolescents and adults. ...
ATLANTA, August 27, 2018 – Micron Biomedical, Inc. (Micron) was awarded a new research contract by the Centers for Disease Control and Prevention (CDC) to continue the development of an IRV-IPV microneedle patch and its GMP manufacturing process. This new research contract comes after Micron successfully completed a Phase 1 SBIR grant and a research contract with the CDC for the ...
AJ Vaccines has initiated a total reconstruction and expansion of its existing Polio vaccine production facilities. The new facilities will increase production capacity substantially while simultaneously ensuring compliance with future WHO demands for Polio vaccine production and containment. AJ Vaccines and the company’s owner have decided to initiate a comprehensive and needed upgrade of ...
Former US Secretary of State Madeleine Albright, along with Muhtar Kent, Chairman and CEO of The Coca-Cola Company, and Walter Isaacson, President and CEO of The Aspen Institute, announced today the formation of the Steering Committee and the Clinton Global Initiative (CGI) commitments for Partners for a New Beginning (PNB). Partners for a New Beginning is a non-partisan, non-profit organization ...
The Combined Federal Campaign of the National Capital Area (CFCNCA) officially kicked off today with a Leadership Conference for more than 600 Federal government employees at the Marriott Renaissance Hotel in Washington, D.C. Campaign leaders announced the 2010 goal of US$67 million to help people and communities in need. Last year, the CFCNCA community of nearly 150,000 civilian, military and ...
Annual volunteer event to commemorate creation of Novartis in 1996 now benefits hundreds of charities in 55 countries More than 20,000 associates worldwide engage in voluntary activities in their communities Novartis event emphasizes ongoing commitment to Corporate Citizenship Thousands of Novartis associates in 55 countries will engage in volunteer activities to benefit people in their ...